• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: macitentan
Date Designated: 06/15/2017
Orphan Designation: Treatment of chronic thromboembolic pulmonary hypertension (CTEPH)
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Actelion Clinical Research, Inc.
1820 Chapel Avenue West
Suite 300
Cherry Hill, New Jersey 08002
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.